D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 44 Citations 7,722 163 World Ranking 2861 National Ranking 177

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Bacteria
  • Immune system

Markus M. Heimesaat spends much of his time researching Immunology, Microbiology, Ileitis, Inflammation and Immune system. In most of his Immunology studies, his work intersects topics such as Inflammatory bowel disease. His Microbiology research incorporates elements of Microbiome, Organism, Gnotobiotic animal, Campylobacter jejuni and Prevotella.

His Campylobacter jejuni research includes themes of Colonisation resistance, Campylobacter and Enterocolitis. The Inflammation study combines topics in areas such as Matrix metalloproteinase, Viral cardiomyopathy and Cytokine. When carried out as part of a general Immune system research project, his work on Toll-like receptor, Gut–brain axis and Host immunity is frequently linked to work in Scientific field, therefore connecting diverse disciplines of study.

His most cited work include:

  • Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii (267 citations)
  • A guide to histomorphological evaluation of intestinal inflammation in mouse models (267 citations)
  • Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. (221 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Microbiology, Immunology, Immune system, Campylobacter jejuni and Inflammation. His work carried out in the field of Microbiology brings together such families of science as Host–pathogen interaction, Virulence and Escherichia coli. Markus M. Heimesaat performs integrative study on Immunology and Ileitis.

Immune system connects with themes related to Tumor necrosis factor alpha in his study. His studies in Campylobacter jejuni integrate themes in fields like Apoptosis, Campylobacter and Enterocolitis. His Toll-like receptor research is multidisciplinary, relying on both Lipopolysaccharide and TLR4.

He most often published in these fields:

  • Microbiology (49.24%)
  • Immunology (48.73%)
  • Immune system (41.62%)

What were the highlights of his more recent work (between 2019-2021)?

  • Microbiology (49.24%)
  • Immune system (41.62%)
  • Campylobacter jejuni (26.40%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Microbiology, Immune system, Campylobacter jejuni, Campylobacteriosis and Antibiotics. His Microbiology research includes elements of Host–pathogen interaction, Virulence, Otitis and Staphylococcus aureus. His study explores the link between Immune system and topics such as Campylobacter coli that cross with problems in Gastrointestinal tract and Interleukin 10.

The study incorporates disciplines such as Secretion, Enterocolitis, Immunology and Resveratrol in addition to Campylobacter jejuni. His study in Gut flora and Inflammation falls within the category of Immunology. His biological study spans a wide range of topics, including Pathogen, Colonisation resistance, Toll-like receptor and Cytokine secretion.

Between 2019 and 2021, his most popular works were:

  • Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis. (18 citations)
  • Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model (12 citations)
  • Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice (10 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Bacteria
  • Immune system

His main research concerns Campylobacter jejuni, Microbiology, Immune system, Campylobacteriosis and Enterocolitis. His study ties his expertise on Immunology together with the subject of Campylobacter jejuni. Markus M. Heimesaat combines subjects such as Host–pathogen interaction and Virulence with his study of Microbiology.

His research on Immune system frequently connects to adjacent areas such as Campylobacter. As a member of one scientific family, Markus M. Heimesaat mostly works in the field of Campylobacteriosis, focusing on Toll-like receptor and, on occasion, Enteritis, Gastrointestinal tract, Interleukin 10 and Immunopathology. His studies in Campylobacter Jejuni Infection integrate themes in fields like Innate immune system, Colonisation resistance and Gut flora.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A guide to histomorphological evaluation of intestinal inflammation in mouse models

Ulrike Erben;Christoph Loddenkemper;Katja Doerfel;Simone Spieckermann.
International Journal of Clinical and Experimental Pathology (2014)

360 Citations

Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii

Markus M. Heimesaat;Stefan Bereswill;André Fischer;David Fuchs.
Journal of Immunology (2006)

351 Citations

Ly6Chi Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis

Luisa Möhle;Daniele Mattei;Markus M. Heimesaat;Stefan Bereswill.
Cell Reports (2016)

292 Citations

Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation

Stefan Bereswill;Melba Muñoz;André Fischer;Rita Plickert.
PLOS ONE (2010)

292 Citations

Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

Melba Muñoz;Markus M. Heimesaat;Kerstin Danker;Daniela Struck.
Journal of Experimental Medicine (2009)

291 Citations

The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.

Martin Witzenrath;Florence Pache;Daniel Lorenz;Uwe Koppe.
Journal of Immunology (2011)

257 Citations

Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4.

Markus M. Heimesaat;André Fischer;Britta Siegmund;Andreas Kupz.
PLOS ONE (2007)

242 Citations

Novel Murine Infection Models Provide Deep Insights into the “Ménage à Trois” of Campylobacter jejuni, Microbiota and Host Innate Immunity

Stefan Bereswill;André Fischer;Rita Plickert;Lea-Maxie Haag.
PLOS ONE (2011)

232 Citations

MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease

Markus M Heimesaat;Axel Nogai;Stefan Bereswill;Rita Plickert.
Gut (2010)

227 Citations

Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity

Stefan F. Martin;Jan C. Dudda;Eva Bachtanian;Annalisa Lembo.
Journal of Experimental Medicine (2008)

224 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Markus M. Heimesaat

Carsten Tschöpe

Carsten Tschöpe

Charité - University Medicine Berlin

Publications: 26

John F. Cryan

John F. Cryan

University College Cork

Publications: 26

Timothy G. Dinan

Timothy G. Dinan

University College Cork

Publications: 22

Anja A. Kühl

Anja A. Kühl

Humboldt-Universität zu Berlin

Publications: 19

Eric Y. Denkers

Eric Y. Denkers

University of Wisconsin–Madison

Publications: 19

Oliver Liesenfeld

Oliver Liesenfeld

Roche (Switzerland)

Publications: 18

Yasmine Belkaid

Yasmine Belkaid

National Institutes of Health

Publications: 18

Britta Siegmund

Britta Siegmund

Humboldt-Universität zu Berlin

Publications: 18

Jochen Huehn

Jochen Huehn

Hannover Medical School

Publications: 18

Norbert Suttorp

Norbert Suttorp

Charité - University Medicine Berlin

Publications: 17

Timothy J. Mitchell

Timothy J. Mitchell

University of Birmingham

Publications: 17

Karin Klingel

Karin Klingel

University of Tübingen

Publications: 17

Steffen Backert

Steffen Backert

University of Erlangen-Nuremberg

Publications: 15

Heinz-Peter Schultheiss

Heinz-Peter Schultheiss

Charité - University Medicine Berlin

Publications: 14

Christopher A. Hunter

Christopher A. Hunter

University of Cambridge

Publications: 14

Sean P. Colgan

Sean P. Colgan

University of Colorado Anschutz Medical Campus

Publications: 12

Trending Scientists

Carsten Schneider

Carsten Schneider

Johannes Kepler University of Linz

David M. Greenberg

David M. Greenberg

University of California, Berkeley

Dong-Yu Kim

Dong-Yu Kim

Gwangju Institute of Science and Technology

Alan Warren

Alan Warren

Natural History Museum

R. Terry Bowyer

R. Terry Bowyer

University of Alaska Fairbanks

John L. Sabo

John L. Sabo

Arizona State University

James Schumacher

James Schumacher

University of Tennessee at Knoxville

Dmitriy M. Chudakov

Dmitriy M. Chudakov

Pirogov Russian National Research Medical University

Alison G. Smith

Alison G. Smith

University of Cambridge

Thomas Ferenci

Thomas Ferenci

University of Sydney

Mitermayer G. Reis

Mitermayer G. Reis

Oswaldo Cruz Foundation

Gary Brierley

Gary Brierley

University of Auckland

Bertram T. Jobson

Bertram T. Jobson

Washington State University

Hirokazu Kanegane

Hirokazu Kanegane

Tokyo Medical and Dental University

Lewis B. Holmes

Lewis B. Holmes

Harvard University

Deirdre N. McCloskey

Deirdre N. McCloskey

University of Illinois at Chicago

Something went wrong. Please try again later.